Pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
September 12, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3644627 Combination of dihydropyridines with angiotensin converting enzymes-inhibitors Stabilized compositions Fused azepinone and azocinone derivatives, processes for their preparation, agents containing them and their use, and intermediates in their preparation Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulations Verapmil therapy Dosage form for delivering drug in short-time period 5236933 Inventors
AssigneeApplicationNo. 522267 filed on 09/12/1995US Classes:424/489, Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)424/451, Capsules (e.g., of gelatin, of chocolate, etc.)424/468, Sustained or differential release type424/472, Layered unitary dosage forms424/473With porous, perforated, apertured, or sieved layer (e.g., dialyzing layer, microporous layer, etc.)ExaminersPrimary: Page, Thurman K.Assistant: Benston, William E. Jr. Attorney, Agent or FirmForeign Patent References
International ClassA61R 009/14Foreign Application Priority Data1994-09-02 SEAbstractThe invention is directed to a pharmaceutical composition which is a combination of the ACE inhibitor ramipril and a calcium antagonist of one of the dihydropyridine type compounds felodipine, nitrendipine, nifedipine and lacidipine. The pharmaceutical composition is for use in the therapy and treatment of hypertension.Other References
Field of SearchParticulate form (e.g., powders, granules, beads, microcapsules, and pellets)Tablets, lozenges, or pills With claimed perfecting feature in contents (e.g., excipient, lubricant, etc.) Layered unitary dosage forms With porous, perforated, apertured, or sieved layer (e.g., dialyzing layer, microporous layer, etc.) Capsules (e.g., of gelatin, of chocolate, etc.) Sustained or differential release type | |
